Neuroblastoma accounts for 15% of total childhood cancer deaths. The survival rate of high-risk neuroblastoma patients is 50%.
For the first time, researchers have discovered that a gene called JMJD6 plays an important role in the most aggressive form of the disease. The research is published in the journal, Nature Communications.
It has long been known that a gain of the chromosomal region 17q is associated with the form of neuroblastoma with the poorer prognosis, however the particular genes within that chromosomal region that are important in neuroblastoma - and therefore are potential drug targets - have until now eluded researchers.
The research team found a candidate gene, called JMJD6, from a tumor data base of 209 patients, finding the gene active in more than one in four patients with the aggressive form of neuroblastoma.
The authors show that JMJD6 forms protein complexes with N-Myc and BRD4, and is important for E2F2, N-Myc and c-Myc transcription. Knocking down JMJD6 reduces neuroblastoma cell proliferation and survival in vitro and tumor progression in mice, and high levels of JMJD6 expression in human neuroblastoma tissues independently predict poor patient prognosis.
In addition, JMJD6 gene is associated with transcriptional super-enhancers. Combination therapy with the CDK7/super-enhancer inhibitor THZ1 and the histone deacetylase inhibitor panobinostat synergistically reduces JMJD6, E2F2, N-Myc, c-Myc expression, induces apoptosis in vitro and leads to neuroblastoma tumor regression in mice, which are significantly reversed by forced JMJD6 over-expression.
The researchers found that after three weeks of drug combination treatment, neuroblastoma tumor size was reduced by 80% compared to the control.
According the senior author similar drugs to the ones used in their experiments are currently in clinical trials for other cancers, making it more likely that this particular treatment strategy will be available for clinical trials of neuroblastoma.
https://www.nature.com/articles/s41467-019-11132-w
A tumorigenic factor in childhood neuroblastoma identified!
- 1,196 views
- Added
Edited
Latest News
How tumor stiffness alters…
By newseditor
Posted 06 Jun
Neural circuit involved in…
By newseditor
Posted 06 Jun
Signaling mechanism in live…
By newseditor
Posted 05 Jun
Statin prevents cancer deve…
By newseditor
Posted 05 Jun
Predicting recovery in pati…
By newseditor
Posted 05 Jun
Other Top Stories
How malaria parasite suppresses the immune response
Read more
Bacteria navigate on surfaces using a 'sense of touch'
Read more
Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 r…
Read more
Risk factors increase brain complications in hospitalized COVID-19…
Read more
Circadian rhythm controls secretion of antimicrobial molecules
Read more
Protocols
Clinical and CSF single-cel…
By newseditor
Posted 05 Jun
ChatGPT-assisted deep learn…
By newseditor
Posted 04 Jun
Turning the tide in aggress…
By newseditor
Posted 03 Jun
Mapping medically relevant…
By newseditor
Posted 01 Jun
Accessible high-speed image…
By newseditor
Posted 30 May
Publications
Cytosolic pH is a direct ne…
By newseditor
Posted 06 Jun
Control of feeding by a bot…
By newseditor
Posted 06 Jun
BCAA-nitrogen flux in brown…
By newseditor
Posted 05 Jun
Mitochondrial GRIM19 Loss I…
By newseditor
Posted 05 Jun
Cofilactin rod formation me…
By newseditor
Posted 05 Jun
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar